What does CUSIP 921659108 represent in this 13F holders report?

CUSIP 921659108 is the security identifier for VNDA - Vanda Pharmaceuticals Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held VNDA - Vanda Pharmaceuticals Inc. - Common Stock in Q2 2020?

159 institutional investors reported VNDA - Vanda Pharmaceuticals Inc. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 59,119,327
Total 13F shares: 55,140,491
Share change: +1,346,480
Total reported value: $630,777,920
Put/Call ratio: 626%
Price per share: $11.44
Number of holders: 159
Value change: +$15,624,266
Number of buys: 82
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 921659108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	15%	9,054,848	$93,809,000	—	31 Mar 2020	13F
ARMISTICE CAPITAL, LLC	13F	Company	7.7%	4,568,000	$47,324,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	7.5%	4,428,915	$45,883,000	—	31 Mar 2020	13F
Palo Alto Investors LP	13F	Company	7%	4,134,846	$42,837,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	6.5%	3,849,654	$39,882,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	5.4%	3,200,963	$33,162,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	4.8%	2,835,916	$29,380,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	2.3%	1,335,345	$13,831,000	—	31 Mar 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	2.2%	1,275,911	$13,218,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2%	1,166,768	$12,086,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	1.4%	799,691	$8,284,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	762,225	$7,896,000	—	31 Mar 2020	13F
Sio Capital Management, LLC	13F	Company	1.2%	721,193	$7,472,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	1.2%	720,076	$7,460,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	1.1%	647,460	$6,708,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.1%	634,547	$6,574,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	1%	611,012	$6,330,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	1%	600,559	$6,221,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.99%	584,972	$6,060,000	—	31 Mar 2020	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.97%	575,252	$5,960,000	—	31 Mar 2020	13F
WINTON GROUP Ltd	13F	Company	0.95%	563,523	$5,838,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.78%	462,345	$4,789,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.71%	417,200	$4,322,000	—	31 Mar 2020	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.7%	412,975	$4,278,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.45%	266,000	$4,267,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.7%	411,552	$4,264,000	—	31 Mar 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.63%	372,102	$3,855,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.56%	328,501	$3,404,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.55%	326,184	$3,379,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.51%	301,776	$3,127,000	—	31 Mar 2020	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.51%	299,800	$3,106,000	—	31 Mar 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.49%	289,126	$2,913,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.47%	280,178	$2,903,000	—	31 Mar 2020	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.47%	278,100	$2,881,000	—	31 Mar 2020	13F
BANK OF MONTREAL /CAN/	13F	Company	0.43%	257,106	$2,833,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.41%	243,070	$2,518,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.4%	234,957	$2,435,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.39%	232,692	$2,411,000	—	31 Mar 2020	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.36%	213,440	$2,211,000	—	31 Mar 2020	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.36%	211,632	$2,193,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.33%	196,489	$2,036,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.3%	175,530	$1,818,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.29%	172,192	$1,784,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.28%	167,411	$1,734,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.27%	159,670	$1,654,000	—	31 Mar 2020	13F
Gotham Asset Management, LLC	13F	Company	0.27%	157,584	$1,633,000	—	31 Mar 2020	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.25%	149,400	$1,548,000	—	31 Mar 2020	13F
QS Investors, LLC	13F	Company	0.25%	148,969	$1,544,000	—	31 Mar 2020	13F
ClariVest Asset Management LLC	13F	Company	0.25%	145,505	$1,507,000	—	31 Mar 2020	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.25%	145,426	$1,507,000	—	31 Mar 2020	13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2020

As of 30 Jun 2020, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,140,491 shares. The largest 10 holders included BlackRock Inc., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Palo Alto Investors LP, STATE STREET CORP, MACQUARIE GROUP LTD, Invesco Ltd., DIMENSIONAL FUND ADVISORS LP, and PRUDENTIAL FINANCIAL INC. This page lists 159 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

154

Q2 2020 holders

159

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.